CA2432945C - Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical - Google Patents

Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical Download PDF

Info

Publication number
CA2432945C
CA2432945C CA002432945A CA2432945A CA2432945C CA 2432945 C CA2432945 C CA 2432945C CA 002432945 A CA002432945 A CA 002432945A CA 2432945 A CA2432945 A CA 2432945A CA 2432945 C CA2432945 C CA 2432945C
Authority
CA
Canada
Prior art keywords
surgery
pyridoxine hydrochloride
doxylamine succinate
medicament
post
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002432945A
Other languages
English (en)
Other versions
CA2432945A1 (fr
Inventor
Brenda Reeve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duchesnay Inc
Original Assignee
Duchesnay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duchesnay Inc filed Critical Duchesnay Inc
Priority to CA002432945A priority Critical patent/CA2432945C/fr
Publication of CA2432945A1 publication Critical patent/CA2432945A1/fr
Application granted granted Critical
Publication of CA2432945C publication Critical patent/CA2432945C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
CA002432945A 2003-07-10 2003-07-10 Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical Expired - Fee Related CA2432945C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002432945A CA2432945C (fr) 2003-07-10 2003-07-10 Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002432945A CA2432945C (fr) 2003-07-10 2003-07-10 Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical

Publications (2)

Publication Number Publication Date
CA2432945A1 CA2432945A1 (fr) 2003-09-28
CA2432945C true CA2432945C (fr) 2004-11-23

Family

ID=28796494

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002432945A Expired - Fee Related CA2432945C (fr) 2003-07-10 2003-07-10 Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical

Country Status (1)

Country Link
CA (1) CA2432945C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2761212A1 (fr) * 2011-12-07 2013-06-07 Pharmascience Inc. Formulation de pyridoxine et de doxylamine a action retardee sans delitant et son procede de fabrication
US10500196B2 (en) 2015-08-17 2019-12-10 Alpha To Omega Pharmaceutical Consultants, Inc. Transdermal and/or topical delivery systems composed of doxylamine succinate and pyridoxine hydrochloride in combination, or alone
AR121619A1 (es) * 2020-03-25 2022-06-22 Inibsa Ginecologia S A Una forma de dosificación oral de múltiples unidades de liberación modificada de succinato de doxilamina y clorhidrato de piridoxina y un procedimiento para su preparación
WO2023101620A1 (fr) * 2021-11-30 2023-06-08 Ilko Ilac Sanayi Ve Ticaret A.S. Composition à libération retardée comprenant de la doxylamine et de la pyridoxine

Also Published As

Publication number Publication date
CA2432945A1 (fr) 2003-09-28

Similar Documents

Publication Publication Date Title
KR20130045241A (ko) 구토방지제로서의 아미설프라이드의 용도
Tarkkila et al. Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine
US7259180B2 (en) Methods and compositions for treatment of macular and retinal disease
US20230138114A1 (en) Treatment of hand eczema
CA2432945C (fr) Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical
US20090203727A1 (en) Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
US20120122919A1 (en) Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist
EP0689437B1 (fr) Utilisation de granisetron dans le traitement de la nausee et des vomissements postoperatoires
US20050004181A1 (en) Use of anti-emetic for pre and post operative care
KR20180066780A (ko) 뇌종양의 예방 또는 치료용 약학 조성물
KR20200026118A (ko) 헬리코박터 파일로리 제균용 조성물
US20190224208A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
US20050234063A1 (en) Therapeutic agent for brain hemorrhage
US20110195987A1 (en) Treatment with cholinergic agonists
NZ249197A (en) Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine in the preparation of medicaments for the treatment or prophylaxis of pain and/or oedema
KR20010024768A (ko) 혈관성 두통에 대한 국소 마취제의 신규 용도
CN115475165B (zh) 马来酸茚达特罗在出血性脑损伤相关疾病中的应用
EP2043669A2 (fr) Compositions et procédés destinés au traitement et à la prévention d'un reflux gastro- sophagien pathologique
KR20190021180A (ko) 퇴행성 신경질환 치료용 복합 제형 조성물
US20070093519A1 (en) Anti-emetic uses of cannabinoid analogs
WO1998038997A1 (fr) Utilisation de la levobupivacaine en association avec des opioides ou des alfa2-agonistes comme anesthesiants ou analgesiques
DAC et al. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION
US6162792A (en) Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
CN114515287A (zh) 一种由莫西沙星和西咪替丁制备的复方制剂及制备方法
Kumar et al. A STUDY ON THE USE OF DEXMEDETOMIDINE AS AN ADJUVANT TO LOCAL ANAESTHESIA FOR TYMPANOPLASTY

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180710